Zscaler Investing Cash Flow increased by 76.0% to -$360.91M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 69774.3%, from $518.00K to -$360.91M. Over 3 years (FY 2022 to FY 2025), Investing Cash Flow shows a downward trend with a 4.5% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q1 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$64.79M | -$67.00K | -$23.87M | $106.52M | $291.49M | -$57.70M | $70.05M | -$91.27M | -$180.42M | -$162.55M | -$86.21M | -$360.24M | -$74.19M | -$201.66M | $518.00K | $21.70M | -$247.58M | -$1.50B | -$360.91M |
| QoQ Change | — | +99.9% | <-999% | +546.2% | +173.7% | -119.8% | +221.4% | -230.3% | -97.7% | +9.9% | +47.0% | -317.9% | +79.4% | -171.8% | +100.3% | >999% | <-999% | -506.8% | +76.0% |
| YoY Change | — | — | — | +264.4% | — | <-999% | +393.4% | -185.7% | -161.9% | -181.7% | -223.1% | -294.7% | +58.9% | -24.1% | +100.6% | +106.0% | -233.7% | -644.9% | <-999% |